Holen Sie sich die Stockscreener-App
7.28
0.55%
0.04
Handel nachbörslich:
7.25
-0.03
-0.41%
Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
10.56%
6.437
|
5.822 | 5.656 | 6.47 | 4.983 |
| Operating Income/Loss |
12.81%
-9.033
|
-8.007 | -8.144 | -8.419 | -6.883 |
| Nonoperating Income/Loss |
33.44%
0.419
|
0.314 | 0.443 | - | - |
| Income/Loss From Continuing Operations Before Tax |
11.97%
-8.614
|
-7.693 | -7.701 | -7.891 | -6.267 |
| Income Tax Expense/Benefit |
0.00%
0.006
|
0.006 | 0.006 | 0.009 | 0.007 |
| Income/Loss From Continuing Operations After Tax |
11.96%
-8.62
|
-7.699 | -7.707 | -7.90 | -6.274 |
Net Income/Loss
|
11.96%
-8.62
|
-7.699 | -7.707 | -7.90 | -6.274 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
15.53%
49.63
|
42.96 | 42.84 | 0.8005 | 42.75 |
| Basic Earnings Per Share |
5.56%
-0.17
|
-0.18 | -0.18 | -0.18 | -0.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):